Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1970 1
1977 2
1978 2
1979 5
1980 4
1981 2
1982 2
1983 4
1984 2
1985 7
1986 7
1987 5
1988 3
1989 8
1990 1
1991 4
1992 6
1993 7
1994 1
1995 5
1996 6
1997 3
1998 9
1999 2
2000 8
2001 6
2002 6
2003 5
2004 7
2005 9
2006 3
2007 8
2008 3
2009 12
2010 7
2011 8
2012 14
2013 16
2014 13
2015 8
2016 7
2017 5
2018 3
2019 11
2020 12
2021 9
2022 4
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Results by year

Filters applied: . Clear all
Page 1
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Among authors: giovanni c. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Clinical Trial.
Cancer immunoprevention.
Lollini PL, De Giovanni C, Pannellini T, Cavallo F, Forni G, Nanni P. Lollini PL, et al. Among authors: de giovanni c. Future Oncol. 2005 Feb;1(1):57-66. doi: 10.1517/14796694.1.1.57. Future Oncol. 2005. PMID: 16555976 Review.
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology.
De Angelis R, Ferri C, Giuggioli D, Bajocchi G, Dagna L, Bellando-Randone S, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Riccieri V, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano AM, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Cipolletta E, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Di Vico C, Gigante A, Pellagrino G, Pigatto E, Lazzaroni MG, Franceschini F, Generali E, Mennillo G, Barsotti S, Mariano GP, Furini F, Vultaggio L, Parisi S, Peroni CL, Rozza D, Zanetti A, Carrara G, Landolfi G, Scirè CA, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'Angelo S, Cozzi F, Guiducci S, Doria A, Salvarani C, Iannone F, Matucci-Cerinic M; SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology). De Angelis R, et al. RMD Open. 2023 Mar;9(1):e002890. doi: 10.1136/rmdopen-2022-002890. RMD Open. 2023. PMID: 36868782 Free PMC article.
CDC25 phosphatase inhibitors: an update.
Lavecchia A, Di Giovanni C, Novellino E. Lavecchia A, et al. Among authors: di giovanni c. Mini Rev Med Chem. 2012 Jan;12(1):62-73. doi: 10.2174/138955712798868940. Mini Rev Med Chem. 2012. PMID: 22070688 Review.
Preclinical vaccines against mammary carcinoma.
Lollini PL, Cavallo F, De Giovanni C, Nanni P. Lollini PL, et al. Among authors: de giovanni c. Expert Rev Vaccines. 2013 Dec;12(12):1449-63. doi: 10.1586/14760584.2013.845530. Expert Rev Vaccines. 2013. PMID: 24195482 Free article. Review.
Barbed palatal surgery: single stage or multilevel setting-a systematic review by the Young Otolaryngologists of the Italian Society of Otolaryngology.
Luca C, Pasquale C, Caterina T, Antonio M, Federico L, Annalisa P, Riccardo A, Giuditta M, Gennaro R, Giovanni C. Luca C, et al. Among authors: giovanni c. Eur Arch Otorhinolaryngol. 2023 Sep;280(9):3905-3913. doi: 10.1007/s00405-023-08018-5. Epub 2023 May 25. Eur Arch Otorhinolaryngol. 2023. PMID: 37227471 Review.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Oncolytic herpes virus retargeted to HER-2.
Lollini PL, Menotti L, De Giovanni C, Campadelli-Fiume G, Nanni P. Lollini PL, et al. Among authors: de giovanni c. Cell Cycle. 2009 Sep 15;8(18):2859-60. doi: 10.4161/cc.8.18.9368. Epub 2009 Sep 26. Cell Cycle. 2009. PMID: 19729994 No abstract available.
280 results